Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lornoxicam vs Etodolac for Third Molar Surgery
NCT05679453Phase 4Completed
- Sponsor
- Kütahya Health Sciences University
- Start
- Jul 2022
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lornoxicam, etodolac in postoperative pain, edema, trismus, sponsored by Kütahya Health Sciences University. Started Jul 2022; status: completed.
02
Drugs
lornoxicametodolac
03
Conditions
postoperative painedematrismus
Beyond the preview
Go deeper on NCT05679453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05679453.